Resources from Radiation Oncology
-
Iodine-125 brachytherapy has been applied to brain tumours since 1979. Even though the physical and biological characteristics make these implants particularly attractive for minimal invasive treatment, the place for stereotactic brachytherapy is still poorly defined. An extensive review of the literature has been performed, especially concerning indications, results and complications.
Radiation Oncology - Tue, 13 March 2012
http://www.ro-journal.com
-
A study reports the experience with intensity-modulated or stereotactic reirradiation in 17 patients suffering from recurrent nasopharyngeal carcinoma, by intensity-modulated (n=14) or stereotactic (n=3) reirradiation. Results show that reirradiation with intensity-modulated or stereotactic techniques in recurrent nasopharyngeal carcinoma is feasible and yields encouraging results in terms of local control and overall survival in patients with acceptable toxicity in patients with less advanced recurrences. However, the achievable outcome is limited in patients with involvement of intracranial structures, emphasising the need for close monitoring after primary therapy.
Radiation Oncology - Tue, 1 March 2011
http://www.ro-journal.com
Page 1 of 1